In March 2025, the company introduced new plans for the direct-to-client featuring of its Wegovy weight loss drug. The company set up a completely new pharmacy, referred to as NovoCare, which would charge shoppers $499 per month for usage of the drug, a lot less than 50 % the cost of the drug as a result of other pharmaceutical distribution network